This project will identify compounds that can improve the efficacy of clinically used chemotherapy, which should ultimately lead to an increase in the overall survival for those breast cancer patients receiving paclitaxel based therapies. It proposes a novel approach to drug screening; one that evaluates drug libraries on breast cancer cells that have just been exposed to clinically used chemotherapy (specifically the chemotherapeutic drug paclitaxel).
Posting date: Fri, 09/23/2016
Award start date: Tue, 08/16/2016
Award end date: Wed, 07/31/2019
